Handbook of Clinical medicine

established on opioids use 1/10th–1/6th of daily dose (see p533 and table 11.5) Agitation + N&V Haloperidol 2.5mg SC (maximum every 1h) Agitation + anxiety Midazolam 2.5mg SC (maximum every 1h) N&V Levomepromazine 6.25mg SC TDS Troublesome Glycopyrronium 200mcg SC every 4–8h respiratory secretions Syringe drivers Syringe drivers (table 11.7) allow a continuous SC infusion of drugs, avoiding re- peated cannulation and injection when the oral route is no longer feasible. Some medications should not be put in the same syringe—check interactions. Take into account regular doses when calculating requirements. If in doubt, seek expert help. Do not forget anticipatory prescribing in addition (table 11.6). Table 11.7 Symptom control medication by SC infusion. Practice is variable, defer to local guidelines fi rst. Indication Drug Subcutaneous dose Pain Morphine If opioid naïve: 10–15mg/24h If on opioids calculate daily opioid dose (consider reducing by 25–30%) then convert (table 11.5) to SC morphine over 24h Anxiety, Midazolam 5–20mg/24h agitation, Levomepromazine 25–75mg/24h delirium Haloperidol 2–10mg/24h N&V Cyclizine 150mg/24h Haloperidol 1–3mg/24h Levomepromazine 6.25–12.5mg/24h (sedation at higher doses) Respiratory Hyoscine butylbromide 60–120mg/24h. Also used for bowel colic secretions Glycopyrronium 600–1200mcg/24h Seizures Seizure prophylaxis: midazolam 20–30mg/24h (may sedate). Dexa- methasone, midazolam and levetiracetam can be given by
